Sigmak Lifesciences supplies WHO-GMP sourced injectable formulations, pharmaceutical APIs, and specialty chemical intermediates to importers, distributors, and healthcare suppliers in Mauritius. Pharmaceutical imports and distribution are governed by the Pharmacy Board of Mauritius and the Food and Drug Division under the Ministry of Health and Wellness.
The injectable portfolio covers antibiotics, analgesics, anti-infectives, cardiovascular agents, vitamins, and essential hospital formulations in ampoule and vial formats. Documentation including COA, COPP, and stability data is available to support Mauritius import and registration requirements.
Mauritius serves as a gateway to the Indian Ocean island markets including Réunion, Comoros, Seychelles, and Madagascar. Sigmak supports customers using Mauritius as a regional distribution base with supply programs structured for multi-market reach.